Quantinuum priced 28 million Class A shares at $60 on June 4, raising $1.68 billion on a 20x oversubscribed book, opening at $68 and closing flat on day one. The S-1 disclosed Q1 2026 revenue of $5.24 million, down 73% from $19.1 million a year earlier, with a net loss of $136.5 million versus $30.5 million in the prior-year quarter. At IPO pricing, the company traded at roughly 453x its full-year 2025 revenue of $30.9 million.

This is the first major pure-play trapped-ion company to go public since IonQ, and the valuation it commands over the next 90 days will function as a real-time benchmark for every private quantum company still eyeing a public listing, including PsiQuantum. A lot of people wanted in before the IPO, but once it was actually trading, nobody was willing to pay more than the opening price. That is the market saying the stock was priced correctly at best, and possibly already too high.

Quantinuum Form S-1, Initial Filing -- SEC EDGAR, May 9, 2026 Quantinuum Form S-1/A, Amendment No. 2 (final pricing) -- SEC EDGAR, June 1, 2026 Quantinuum closes flat in Nasdaq debut, after upsized offering -- CNBC, June 4, 2026 Sandia National Laboratories and Quantinuum publish Helios results in Nature -- Sandia National Laboratories press release, June 17, 2026 Sandia and Quantinuum Validate 98-Qubit Helios Trapped-Ion Framework -- Quantum Computing Report, June 2026 Helios Nature paper -- Nature, DOI: 10.1038/s41586-026-10676-4, June 17, 2026